Prepare for your visit
Ryan W Jacobs
Hematology (Internal Medicine) · Charlotte, NC · NPI 1114160082
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,543,104.31
in general payments reported to CMS, 2019-2025 · $219K in 2025
The $219K reported for 2025 was more than what 99% of Hematology (Internal Medicine) providers received nationally (typical 2025 total: $1,177).
Who reported paying
General payments only, top 6 by amount.
- Astrazeneca Pharmaceuticals LP $235,948.76
- Abbvie INC. $224,506.42
- Janssen Biotech, INC. $194,283.04
- Beigene USA, INC. $189,683.23
- Pharmacyclics LLC, An Abbvie Company $180,116.85
- Secura Bio, INC. $153,620.16
Drugs and devices associated with these payments
Brukinsa Calquence Copiktra Epkinly Imbruvica Venclexta Clonoseq Yescarta Lumoxiti Jaypirca Lunsumio Onivyde
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Ryan Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/423472/ryan-w-jacobs